This international event evaluates the status, opportunities and threats for medical device companies conducting business in Japan, India, China, Hong Kong, Australia, Europe and the U.S. now and in the future. Keeping you up to date with all developments, you will gain comprehensive and comparative analysis of key markets.

The event aims to:
> Make those involved in the development of devices and device/drug combinations familiar with current global regulatory requirements
> Compare and contrast regulatory processes in the major regions (EC, USA, Japan)
> Introduce the regulatory expectations from developing markets such as India, Hong Kong and China
> Review case studies for successful development and approval of device products and offer practical guidance
> Share evolving regulatory challenges represented by the revisions to the Medical Device Directive and the Global Harmonization Task Force

Registration required:

Yes

Free:

No